Micol Frassi

4.4k citations
74 papers · 3.4k · 2 hit papers · h-index 24

Impact in

  • Rheumatology top 0.5%
    • Systemic Lupus Erythematosus Research
    • Eosinophilic Disorders and Syndromes
  • Hematology top 2%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Systemic Lupus Erythematosus Research 15
    • Otitis Media and Relapsing Polychondritis 11
    • Autoimmune and Inflammatory Disorders Research 17

Micol Frassi

69 papers receiving 3.2k citations

Micol Frassi's Hit Papers

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 2020 · 607 citations
6070+7+14Years since publication200400600

Peers

Micol Frassi
Comparison fields: 5 of 103
  • Rheumatology 1.4k
  • Hematology 487
  • Immunology 627
  • Infectious Diseases 510
  • Neurology 326
Replace Ilaria Cavazzana with:
Ilaria Cavazzana Italy
Karim Sacré France
Alí Duarte‐García United States
Akio Mimori Japan
Elena Marina Baldissera Italy
Antoine Néel France
Rosario García-Vicuña Spain
Ignacio García‐De La Torre Mexico
Cécile Yelnik France
José Alfredo Gómez-Puerta Spain
Micol Frassi relative to Ilaria Cavazzana Italy Ilaria Cavazzana's profile →
Citations per field
00.5×1.5×2.2×
Ilaria Cavazzana · 1×
Citations per year

Countries citing papers authored by Micol Frassi

Since Specialization
Citations

This map shows the geographic impact of Micol Frassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micol Frassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micol Frassi more than expected).

Fields of papers citing papers by Micol Frassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micol Frassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micol Frassi. The network helps show where Micol Frassi may publish in the future.

Co-authors

The 25 scholars most cited alongside Micol Frassi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Micol Frassi Line = papers co-authored together Micol Frassi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Hit paper breakdown →
2020607
2
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg‐Strauss syndrome
Hit paper breakdown →
2005539
3 2001396
4 2002122
5 2016119
6 2004116
7 2019116
8 2020108
9 201795
10 201082
11 201678
12 201874
13 200473
14 200971
15 200546
16 202334
17 201134
18
Reduction of peripheral blood T cells producing IFN-γ and IL-17 after therapy with abatacept for rheumatoid arthritis.
201432
19 201932
20
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase.
200730

About Micol Frassi

Micol Frassi is a scholar working on Rheumatology, Hematology, Immunology, Ophthalmology and Pathology and Forensic Medicine, having authored 74 papers that have together received 3.4k indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (17 papers), Systemic Lupus Erythematosus Research (15 papers), Otitis Media and Relapsing Polychondritis (11 papers), Inflammasome and immune disorders (9 papers), Ocular Diseases and Behçet’s Syndrome (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Kawasaki Disease and Coronary Complications (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Rheumatology (1.4k citations), Hematology (487 citations), Immunology (627 citations), Infectious Diseases (510 citations) and Neurology (326 citations). Micol Frassi has collaborated with scholars based in Italy, Egypt and Türkiye. Frequent co-authors include Anǵela Tincani, Andrea Lojacono, Franco Franceschini, Andrea. Schwartz Doria, Pier Luigi Meroni, Mario Motta, Laura Pavone, Umberto Maggiore, Stefano Monti and Antonella Radice. Their work appears in journals such as Frontiers in Medicine, Lupus, Frontiers in Pharmacology, Internal and Emergency Medicine and Autoimmunity Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact